A Phase III Study of Induction Pembrolizumab and Chemotherapy Followed by Chemoradiation and Pembro

The purpose of this study is to compare the usual treatment alone (chemoradiation and pembrolizumab followed by pembrolizumab) to using induction chemotherapy therapy with pembrolizumab before chemoradiation and pembrolizumab followed by pembrolizumab. The addition of providing induction therapy (carboplatin, paclitaxel, and pembrolizumab) prior to the usual chemoradiation and pembrolizumab therapy could shrink your cancer or prevent it from returning